Clinical Trial Update: Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interferon alfa, isotretinoin, and paclitaxel in patients with recurrent small cell lung cancer completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Interferon Alfa (interferon alfa)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-04